v3.26.1
Segment Information
6 Months Ended
Jun. 30, 2026
Segment Information  
Segment Information

18.Segment Information

The Company views its operations and manages its business in one operating segment, which also represents one reportable segment which derives its revenues from diabetes products and services. Operating segments are defined as components of an enterprise about which separate discrete information is available for evaluation by the chief operating decision maker (“CODM”), or decision-making group, in deciding how to allocate resources and in assessing performance. The Company’s CODM, its Chief Executive Officer, manages the Company’s operations on a consolidated basis for the purpose of allocating resources.

The CODM assesses performance for the segment based on net loss, which is reported in the consolidated statements of operations and comprehensive loss and uses the financial information in deciding on how to invest into the Company. The measure of segment assets is reported on the balance sheets as total assets.

The table below summarizes the significant expense categories regularly reviewed by the CODM for the six months ended June 30, 2026 and 2025:

Three Months Ended

Six Months Ended

June 30, 

June 30, 

2026

2025

2026

2025

Total revenue

$

14,483

$

6,649

$

26,194

$

12,906

Less:

Cost of sales

5,924

3,528

10,695

8,280

Sales and marketing expenses

 

21,245

 

2,800

40,974

 

4,542

Research and development expenses

 

11,639

 

7,715

20,250

 

15,014

General and administrative expenses

11,663

6,929

22,109

12,881

Other Segment Items(1)

717

178

1,204

949

Net Loss

$

(36,705)

$

(14,501)

$

(69,038)

$

(28,760)

(1)Other segment items include interest income, interest expense, and other expense as presented in the Company’s consolidated statements of operations and comprehensive loss.